RDY (Dr. Reddy's Laboratories Limited American Depositary Shares) Stock Analysis - SEC Filings

Dr. Reddy's Laboratories Limited American Depositary Shares (RDY) is a publicly traded Healthcare sector company. As of May 21, 2026, RDY trades at $13.63 with a market cap of $11.32B and a P/E ratio of 0.00. RDY moved +1.23% today. Year to date, RDY is -1.37%; over the trailing twelve months it is -6.00%. Its 52-week range spans $12.19 to $16.19. Analyst consensus is sell with an average price target of $0.00. Rallies surfaces RDY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find RDY SEC filings?

Rallies organizes RDY SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

RDY Key Metrics

Key financial metrics for RDY
MetricValue
Price$13.63
Market Cap$11.32B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.11%
52-Week High$16.19
52-Week Low$12.19
Volume10
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest RDY News

RDY Analyst Consensus

1 analysts cover RDY: 0 strong buy, 0 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is sell. Average price target: $0.00.

Common questions about RDY

Where can I find RDY SEC filings?
Rallies organizes RDY SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show RDY 10-K and 10-Q filings?
Rallies organizes RDY SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is RDY research on Rallies investment advice?
No. Rallies provides research, data, and educational context for RDY. It does not provide personalized investment advice.
RDY

RDY